Cardiac Myosin-binding Protein C in ST-elevation Myocardial Infarction
cMyC is a quantitative biochemical biomarker of myocardial injury in reperfused STEMI. Further studies, using optimised high-sensitivity assays, are warranted to evaluate its potential as a novel biomarker after acute MI.
Authors
- Ranil de Silva
- Liam S. Couch (ORCID: https://orcid.org/0000-0002-9926-2574)
- Alexander Tindale (ORCID: https://orcid.org/0000-0002-8199-4275)
- Sam Whitman McGrath (ORCID: https://orcid.org/0009-0000-5383-1885)
- Michael Marber (ORCID: https://orcid.org/0000-0002-3463-7128)
- Zohya Khalique (ORCID: https://orcid.org/0000-0002-0977-4796)
- Catherine Beattie
- Bashir Alaour (ORCID: https://orcid.org/0000-0001-5604-1096)
- Dudley J. Pennell (ORCID: https://orcid.org/0000-0001-5523-1314)
- Emily-Jane Cantor
- Ramyah Rajakulasingam
- Emanuela Falaschetti
- Miles C. Dalby
- Yamam Sbeih
Institutions
- King's College London (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Harefield Hospital (GB)
- Lung Institute (US)
- Imperial College London (GB)
Publication Details
- Journal
- European Heart Journal Acute Cardiovascular Care
- Published
- 2026-03-21
- DOI
- https://doi.org/10.1093/ehjacc/zuag032
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00